• LinkedIn Social Icon

© 2016-2019 Cayenne Law.

Attorney advertising. Prior results do not guarantee a similar outcome.

Some of Jerry Marr's prior Life Sciences representations

  • Ophthotech in its >$1 billion ex-US licensing and commercialization agreement for FOVISTA™ with Novartis
     

  • A biopharmaceutical client in a >$1 billion oral diabetes drug collaboration with a global pharmaceutical company
     

  • A biopharmaceutical client in a >$1 billion worldwide hepatitis C collaboration with a global pharmaceutical company
     

  • A global pharmaceutical client in a >$1 billion deal licensing a prostate cancer immunotherapy from an international biotechnology company
     

  • An antibody discovery technology client in platform licensing agreements with four global pharmaceutical companies
     

  • Two major universities in the spin out and formation of a major biomedical and genomic research institute
     

  • A biopharmaceutical client in a spinal muscular atrophy collaboration with a global pharmaceutical company and a charitable foundation
     

  • A biopharmaceutical client in license and research agreements with a major hospital for orphan drug candidates